Replies to post #11332 on Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

<<the surveyed neurologists weren’t asked how many patients they expected to switch back from thrice-weekly Copaxone to a generic version of daily (20mg) Copaxone, so the survey doesn’t inform in this regard.>>

What is your best guess regarding how this plays out?

[rajaram46]

And today the movement is the opposite...